Patterned Stem Cell Culture for Controlled Retinal Tissue Formation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for producing retinal tissues from pluripotent stem cells, such as the SFEBq method, face challenges in controlling tissue morphology and size, difficulty in drug delivery and observation within the cell mass, and lack of automation suitability.
Innovation Solution
A method involving seeding pluripotent stem cells on a culture substrate with distinct adhesive regions (A and B) and culturing them in media containing ROCK inhibitors and BMP signaling activators to induce retinal tissue differentiation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Stability of the object's composition
If the SFEBq method is used to produce retinal tissue, then three-dimensional tissues can be formed with good reproducibility, but the patterning process cannot be controlled and morphology and size of tissues cannot be controlled
Solution Approach 1:
The culture substrate is divided into a patterned adhesive region and a non-adhesive region, allowing spatial segmentation of cell growth. This enables precise control over where cells adhere and proliferate, thereby controlling tissue morphology and size while maintaining reproducibility through defined geometric patterns.
Solution Approach 2:
The adhesive region is designed with specific local properties (adhesive vs. non-adhesive areas) to guide cell behavior. By creating localized adhesive zones with defined geometries, the method controls tissue morphology and size at specific locations while maintaining overall process reproducibility.
2Adaptability or versatility
If the SFEBq method is used to produce retinal tissue, then self-assembly of cells is utilized, but it is difficult for drugs to reach cells within the cell mass and difficult to observe inside cells
Solution Approach 1:
The invention transitions from three-dimensional cell mass (SFEBq method) to two-dimensional patterned monolayer culture. This dimensional change allows drugs to easily reach all cells and enables straightforward observation of inside cells through the flat, organized structure while still allowing self-assembly processes to occur within the constrained geometric patterns.
3Reliability
If the SFEBq method is used to produce retinal tissue, then differentiation can be induced, but the method is not considered to be suited for automation
Solution Approach 1:
The invention changes the cultural parameters from suspension culture (SFEBq) to adherent monolayer culture on patterned substrates. This parameter change enables automation because adherent cells can be easily manipulated by standard automated cell culture equipment, while differentiation induction is maintained through controlled adhesive patterns and culture conditions.
4Productivity
If pluripotent stem cells are seeded at high density, then cell mass forms quickly, but tissue morphology and size cannot be controlled
Solution Approach 1:
The substrate is segmented into adhesive and non-adhesive regions, confining cell growth to specific patterned areas. This allows high-density seeding to proceed quickly for productivity while the adhesive pattern geometry controls the final tissue morphology and size, resolving the contradiction between speed and precision.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method enables the production of retinal tissues with controlled morphology and size, facilitating drug delivery and observation, and allows for automated production.
Implementation Method 1
seeding pluripotent stem cells on a region A of a surface of a culture substrate
Implementation Method 2
culturing them in media containing ROCK inhibitors and BMP signaling activators to induce retinal tissue differentiation
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The present disclosure includes a method of producing a retinal tissue, comprising steps of (1) seeding pluripotent stem cells on a region A of a surface of a culture substrate at a density of 0.5 × 105 cells/cm2 to 2.5 × 105 cells/cm2, wherein the culture substrate comprises the region A and a region B on the surface, the region A has cell adhesiveness, and the region B is adjacent to at least a part of the region A and has cell adhesiveness lower than the cell adhesiveness of the region A, (2) culturing the pluripotent stem cells seeded in the step (1) in a medium containing a ROCK inhibitor for 1 to 16 hours, and (3) culturing cells obtained after the step (2) in a medium containing a BMP signaling activator; a retinal tissue produced by the method; and a composition comprising the retinal tissue.